Targeted Cancer Therapies
Sorafenib
BPT-1209 · Tablet
What is it used for?
Blocks several signaling pathways that support tumor growth and blood-vessel formation. Used for specified unresectable liver cancer, advanced kidney cancer and differentiated thyroid cancer resistant to radioactive iodine.
- Dosage form
- Tablet
- Listed strengths
- 200 mg
- Listed pack size
- 28's
- Mechanism
- Multikinase inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Unresectable hepatocellular carcinoma
- Advanced renal cell carcinoma
- Selected differentiated thyroid cancers
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information
